Filter posts

Word on the Street – Biotech Stocks Only Have Room to Go Up

The Opening Lunch Plenary at this year’s BIO CEO & Investor Conference was a lively …

Celgene CEO on New Multiple Myeloma Drug Approvals

Following on the heels of two big announcements in February, Celgene CEO Robert Hugin (one …

Simpson Bowles Keynote to Address Debt, Taxes, Government Services and Politics

I was recently asked what the single biggest threat to the biotechnology industry is today.  …

2013 BIO International Convention Program Highlights

I’m thrilled to be attending the upcoming 2013 BIO International Convention that is coming to …

Delivering on the Promise of Personalized Medicine

As sequencing moves out of the lab and into the clinic, a host of players …

BIO Housing Inventory Going Fast

With roughly 80,000 bioscience jobs in more than 3,500 businesses across all bioscience sectors, it …

20th Anniversary of the BIO International Convention

Next year BIO will celebrate the 20th anniversary of the BIO International Convention April 22-25 …

eAdvocacy Summit Brings Together More Than 130 Groups

BIO’s mission is to champion biotechnology issues by advocating for policies that will enable the …

BIO Investor Forum - Raring to Go: The Race to Treat Ultra-Rare Diseases

The signing of FDASIA by President Obama in July reinforces the country’s commitment to fostering …

BIO India Hosts Biopharmaceutical Regulatory and Policy Roundtable

During last week’s BIO India International Conference, BIO, in partnership with the Association of Biotech-Led …